XNAS · Healthcare · Medical - Diagnostics & Research
Prenetics Global Ltd is a consumer health and wellness company offering nutrition and longevity products through its flagship brand, IM8. It offers science-backed daily nutrition and longevity products distributed directly to consumers across multiple countries. The company's products are developed with scientific input and are subject to third-party quality certifications.
Prenetics delivered a **mixed-to-weak** Q2: revenue surged to **$46M** from $18M, but it still missed estimates and posted **-$0.53 EPS**, suggesting growth is being funded by losses. In diagnostics, the core issue is execution quality, not demand.
AI-generated summary — powered by BigEarnings.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 | Q2 2026 | -0.45 | -0.53 | -17.78% | $46.5M | ❌ Miss | +4.13% | +19.85% | — |
| 2026-06-10 | Q1 2026 | -0.49 | -1.61 | -228.57% | $36.0M | ❌ Miss | +1.67% | +3.14% | -7.22% |
| 2026-02-18 |
| Q4 2025 |
| — |
| -1.77 |
| — |
| $36.6M |
| — |
| +1.15% |
| -15.55% |
| -2.19% |
| 2025-11-10 | Q3 2025 | -0.29 | -0.41 | -41.38% | $23.6M | ❌ Miss | — | — | — |
| 2025-09-12 | Q2 2025 | -0.57 | -0.82 | -43.86% | $17.7M | ❌ Miss | — | — | — |
| 2024-11-27 | Q3 2024 | -0.86 | -0.84 | +2.33% | $7.8M | ✅ Beat | +1.13% | -0.70% | +28.75% |
| 2024-10-07 | Q2 2024 | -0.93 | -0.88 | +5.38% | $5.9M | ✅ Beat | -8.91% | -4.57% | -12.32% |
| 2024-06-18 | Q1 2024 | — | -0.38 | — | $6.4M | — | +2.35% | +2.35% | -4.02% |
Showing last 8 quarters.